Contribute Try STAT+ Today

In what is being described as a “major breakthrough,” a World Trade Organization council agreed to start formal negotiations over a controversial proposal to temporarily waive intellectual property protections on Covid-19 vaccines in hopes of widening global access.

The step came after months of debate over the proposal, which gained significant momentum after the Biden administration last month unexpectedly agreed to support the initiative, which had been met with pushback by the pharmaceutical industry. The about-face occurred as a lack of vaccines in many low-income countries threatened to prolong the pandemic, especially as new variants emerge.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment